Department of Plastic, Reconstructive and Hand Surgery, Radboud University Medical Center, Nijmegen, the Netherlands.
Medical Biology, Faculty of Science, Radboud University, Nijmegen, the Netherlands.
Gene. 2019 Jun 15;701:89-97. doi: 10.1016/j.gene.2019.03.021. Epub 2019 Mar 19.
With the introduction of vascularized composite allotransplantation (VCA) as new surgical technique, the need arose for strategies that could safely prolong graft preservation. Ex-vivo machine perfusion is a promising technique and is currently applied in solid organ transplantation. There is still limited evidence in the field of VCA and free flap transplantation. This gene expression study aimed to assess the degree of ischemia-reperfusion (IR) injury after preservation and replantation of free muscle flaps in a porcine model.
A microarray analysis was first conducted on muscle flaps preserved by ex-vivo perfusion versus cold storage, to select genes of interest for further investigation. The expression of these selected genes was then examined in a muscle flap replantation model after 18 hour ex-vivo perfusion (n = 14) using qRT-PCR. Two preservation solutions were compared to static cold storage: University of Wisconsin-mp (n = 5) and Histidine-Tryptophan-Ketoglutarate solution (n = 5).
A selection of 8 genes was made based on micro-array results: Tumor necrosis factor receptor superfamily member 10-A like, Regulator of G-protein signaling 2, Nuclear factor kappa beta inhibitor zeta, Interleukin-1 beta, Fibroblast growth factor 6 and DNA damage-inducible transcript 4, Hypoxia-inducible factor 1-alpha and Caspase-3. The muscle flap replantation experiment compared their expression patterns before and after preservation and replantation and showed overall comparable gene expression between the preservation groups.
The expression of genes related to ischemia, apoptosis and inflammation was comparable between the ex-vivo perfusion and static cold storage groups. These results suggest that ex-vivo perfusion might be a promising technique for 18 hour muscle preservation in terms of decreasing ischemia-reperfusion injury.
随着血管化复合组织同种异体移植(VCA)作为一种新的外科技术的引入,需要寻找能够安全延长移植物保存时间的策略。离体机器灌注是一种很有前途的技术,目前已应用于实体器官移植。在 VCA 和游离皮瓣移植领域,相关研究仍十分有限。本基因表达研究旨在评估猪模型中游离肌肉瓣经离体灌注保存和再植后缺血再灌注(IR)损伤的程度。
首先对离体灌注保存与冷藏保存的肌肉瓣进行微阵列分析,以选择进一步研究的感兴趣基因。然后使用 qRT-PCR 在离体灌注 18 小时后的肌肉瓣再植模型中检查这些选定基因的表达(n=14)。将两种保存液与静态冷藏进行比较:威斯康星大学(UW)-mp(n=5)和组氨酸-色氨酸-酮戊二酸溶液(n=5)。
基于微阵列结果选择了 8 个基因:肿瘤坏死因子受体超家族成员 10-A 样、G 蛋白信号调节因子 2、核因子 kappa beta 抑制剂 zeta、白细胞介素 1 beta、成纤维细胞生长因子 6 和 DNA 损伤诱导转录物 4、缺氧诱导因子 1-alpha 和 Caspase-3。肌肉瓣再植实验比较了它们在保存和再植前后的表达模式,结果显示两组之间的基因表达总体上具有可比性。
离体灌注和静态冷藏组之间与缺血、细胞凋亡和炎症相关的基因表达相当。这些结果表明,离体灌注可能是一种有前途的技术,可以在 18 小时内减少缺血再灌注损伤,从而保存肌肉。